Dr. Wurapa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2665 N Decatur Rd
Suite 330
Decatur, GA 30033Phone+1 404-297-9755
Education & Training
- University of RochesterFellowship, Infectious Disease, 1997 - 1999
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
- SUNY Upstate Medical UniversityClass of 1994
Certifications & Licensure
- GA State Medical License 2001 - 2025
- NY State Medical License 1997 - 2003
- OH State Medical License 1995 - 1998
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 13 citationsSwitching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.Debbie Hagins, Princy Kumar, Michael S. Saag, Anson K Wurapa, Indira Brar
Journal of Acquired Immune Deficiency Syndromes. 2021-09-01 - 24 citationsDolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson K Wurapa
AIDS. 2021-10-01 - 8 citationsSustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa
Open Forum Infectious Diseases. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: